EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring Artificial Intelligence's Potential to Enhance Conventional Anticancer Drug Development

Sorin-Ștefan Bobolea iD, Miruna-Ioana Hinoveanu, Andreea Dimitriu, Miruna-Andrada Brașoveanu, Cristian-Nicolae Iliescu, Cristina-Elena Dinu-Pîrvu, Mihaela Violeta Ghica, Valentina Anuța, Lăcrămioara Popa, Răzvan Mihai Prisada

Drug Development Research · 2025

DOI: 10.1002/ddr.70182 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Development Research, 2025. Verfasst von Sorin-Ștefan Bobolea und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical and Colloidal Chemistry, Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. Hauptthemen laut MEDLINE: Artificial Intelligence, Antineoplastic Agents, Drug Development, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 342 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Institutional Development Fund, CNFIS-FDI-2025-F-0646 and by the Resilience Plan of Romania - Pillar III-C9-I, section I5, Esta….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer affects one in three to four people globally, with over 20 million new cases and 10 million deaths annually, projected to rise to 35 million cases by 2050. Developing effective cancer treatments is crucial, but the drug discovery process is a highly complex and expensive endeavor, with success rates sitting well below 10% for oncologic therapies. More recently, there has been a growing interest in Artificial intelligence (AI) due to its potential to significantly enhance the success rates by processing large data sets, identifying patterns, and making autonomous decisions. The primary aim of this literature review is to examine the potential that state‐of‐the‐art AI tech‐nologies have to enhance and complement well‐established research methods used in cancer drug development, such as QSAR, interactions prediction, and ADMET prediction, among others. The basic technical aspects of computational technologies are clarified, and key terms commonly asso‐ciated with AI are defined. Current applications and case studies from academia and industry are presented to highlight AI's potential to accelerate progress in cancer drug research. Challenges and disadvantages of AI are also acknowledged, and it is discussed that future research should focus on overcoming its limitations to maximize its impact in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceAntineoplastic AgentsDrug DevelopmentNeoplasmsHumansDrug DiscoveryQuantitative Structure-Activity Relationship

Stichwörter der Autor:innen

artificial intelligence (AI)cancercomputational modelsdeep learning (DL)drug developmentmachine learning (ML)neural networks (NN)

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Physical and Colloidal Chemistry, Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
  • Innovative Therapeutic Structures Research and Development Centre (InnoTher), "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

ORCID-Profile: Sorin-Ștefan Bobolea

Förderung

  • This study was supported by the Institutional Development Fund, CNFIS-FDI-2025-F-0646 and by the Resilience Plan of Romania - Pillar III-C9-I, section I5, Esta…

Zitieren

APA

Bobolea, S. Ș., Hinoveanu, M. I., Dimitriu, A., Brașoveanu, M. A., Iliescu, C. N., Dinu-Pîrvu, C. E., Ghica, M. V., Anuța, V., Popa, L., & Prisada, R. M. (2025). Exploring Artificial Intelligence's Potential to Enhance Conventional Anticancer Drug Development. Drug Development Research. https://doi.org/10.1002/ddr.70182

Vancouver

Bobolea SȘ, Hinoveanu MI, Dimitriu A, Brașoveanu MA, Iliescu CN, Dinu-Pîrvu CE, et al. Exploring Artificial Intelligence's Potential to Enhance Conventional Anticancer Drug Development. Drug Development Research. 2025. doi:10.1002/ddr.70182

BibTeX
@article{Bobolea2025,
  author = {Bobolea, Sorin-Ștefan and Hinoveanu, Miruna-Ioana and Dimitriu, Andreea and Brașoveanu, Miruna-Andrada and Iliescu, Cristian-Nicolae and Dinu-Pîrvu, Cristina-Elena and Ghica, Mihaela Violeta and Anuța, Valentina and Popa, Lăcrămioara and Prisada, Răzvan Mihai},
  title = {Exploring Artificial Intelligence's Potential to Enhance Conventional Anticancer Drug Development},
  journal = {Drug Development Research},
  year = {2025},
  doi = {10.1002/ddr.70182}
}
Kostenlos starten →